Relation of Helicobacter pylori infection and angiographically demonstrated coronary artery disease

C J Tsai1, T Y Huang

  • 1Department of Internal Medicine, Chi Mei Foundation Hospital, Yung Kang City, Tainan, Taiwan.

Insights

This study investigated the link between Helicobacter pylori (H. pylori) infection and coronary heart disease. Researchers found no significant association between H. pylori seropositivity and increased risk of coronary artery disease.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Conventional coronary risk factors do not fully explain coronary heart disease (CHD) incidence.
  • Helicobacter pylori (H. pylori) genomic material has been detected in coronary arteries of myocardial infarct patients.
  • Investigating H. pylori as a potential coronary risk factor is warranted.

Purpose of the Study:

  • To determine if H. pylori infection is associated with an increased risk of coronary heart disease.
  • To explore the relationship between H. pylori seropositivity and coronary artery lesions.

Main Methods:

  • Prospective study of patients undergoing coronary angiography.
  • Cases (N=165) had ≥50% coronary artery lesions; controls (N=127) had normal angiography.
  • Serum IgG antibodies to H. pylori were measured using ELISA; demographic, cardiovascular risk, and socioeconomic data were collected.

Main Results:

  • H. pylori seropositivity was not significantly associated with coronary artery disease (OR 0.66, P=0.12), even after adjustment (OR 0.59, P=0.09).
  • No association was found between H. pylori seropositivity and conventional cardiovascular risk factors.
  • A trend of higher H. pylori positivity in cases with more severe coronary artery disease was not statistically significant.

Conclusions:

  • This study found no increased seropositivity for H. pylori in subjects with coronary artery disease.
  • Previous H. pylori infection may not be a significant factor in determining coronary heart disease risk.
  • Further research is needed to fully understand the complex interplay between infections and cardiovascular health.

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...